Kaken Pharmaceutical Co.,Ltd.

Kaken Pharmaceutical Co., Ltd. (Kaken Pharmaceutical) is a Japan based pharmaceutical company engaged in the development, production and sale of the pharmaceutical drugs and agrochemicals. The company operates in two business segments: Pharmaceutical and Real Estate. The Pharmaceutical segment manufactures and sells pharmaceuticals, quasi-drugs, medical equipment, veterinary drugs, agricultural chemicals and additives for feeds. The Real Estate segment is engaged in the leasing of real estate and the maintenance of buildings. Its product portfolio includes, Pharmaceutical and Medical Devices, Agrochemicals and Animal Health Products including Lipidil, Seprafilm, Mentax, Artz, Adofeed, Procylin, Generic Drugs, Fiblast Spray, Polyoxins, Colistin sulfate, Salinomycin, Berasus, Ebrantil, Pentoxazone and Cytotec. Kaken Pharmaceutical markets these products under the various brands such as Lotrimin Ultra, Dermax, and Mentax. It markets these products in the regions of Korea, Taiwan, Germany, Belgium, Philippines, Canada, and the US. The company is headquartered in Tokyo, Japan.

Street: 
28-8
City: 
Bunkyo-ku
Postcode: 
113-8650
Federal State : 
Japan
WebSite: 
www.kaken.co.jp/english
Fax: 
--81 3 59775131

Company Index Score

Current Index Score Historical Index Score
  • Kaken Pharmaceutical Co.,Ltd. currently scores 50 % in the index.
  • Kaken Pharmaceutical Co.,Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Kaken Pharmaceutical Co.,Ltd. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets